As COVID vigilance dwindles, medical companies ail

Many medical businesses thrived early in the pandemic. But now, domestic producers of personal protective equipment are struggling, COVID test makers have shuttered and vaccine developer Pfizer cut its revenue forecast for the year by $9 billion. In this episode, what might be next for the COVID economy. Plus, we’ll meet a writer who followed a meal literally from farm to table and visit two states that offer very different opportunities for remote work.